MedPath

Comparison of Smoking and Vaping in Families

Completed
Conditions
Smoking
Interventions
Other: Saliva sample
Other: Urine Sample
Other: Toe nail clippings
Other: Breath carbon monoxide test
Registration Number
NCT02500238
Lead Sponsor
University of Florida
Brief Summary

Electronic cigarette use may be less harmful than cigarettes in adults, however, limited data exists examining passive electronic cigarette exposure and child health outcomes. The current study seeks to compare health-related outcomes among youth who reside with non-smokers, cigarette smokers, and electronic cigarette users. The investigators propose to conduct a small pilot study with 30 youth, ages 6-17 and a caregiver. Three groups of 10 parent-child dyads will be recruited: 1) control group: parents who are non-smokers/non-vapers, 2) smoking group: parents who are exclusive cigarette smokers, and 3) vaping group: parents who are exclusively ECIG users. Groups will be compared across the following variables: child lung function and biomarkers of nicotine.

Detailed Description

The current study seeks to compare health-related outcomes among youth who reside with non-smokers, cigarette smokers, and electronic cigarette users.

Control Group: will consist of participants ages 6 - 17 who live in a home with adults who do not smoke. A brief breathing test will verify a non-smoker and/or are not around a certain amount of smoke in the environment (live with a smoker). The participant will be asked to complete a series of brief questionnaires that asks about basic demographic information, medical history, and that asks about their smoking history. The participant's will also be asked to complete two 5 minute breathing tests, provide a sample of saliva, a urine sample, and have their toe nails clipped.

Vaping Group: will consist of participants ages 6 -17 who live in a home with adults who currently use electronic cigarettes. A brief breathing test will verify a non-tobacco smoker and/or are not around a certain amount of smoke in the environment (live with a tobacco smoker). The participant will be asked to complete a series of brief questionnaires that asks about basic demographic information, smoking or vaping history and patterns of use, and medical history. The participant will be asked to complete two 5 minute breathing tests, provide a sample of saliva, a urine sample, and have their toe nails clipped.

Smoking Group: will consist of participants ages 6 - 17 who live in a home with adults who currently smoke cigarettes. Participants will then be asked to complete a series of brief questionnaires that asks about basic demographic information, smoking or vaping history and patterns of use, and medical history. The participant will also be asked to complete two 5 minute breathing tests, provide a sample of saliva, a urine sample, and have their toe nails clipped.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria

For the control group the caregiver must self-report:

  1. never smoking or not smoking for at least the past 12 months;
  2. that no one living in the home is a current smoker or has smoked in the home for the past 6 months; and
  3. have a breath carbon monoxide reading of ≤ 6ppm.

For the smoking group caregivers must:

  1. smoke at least 10 cigarettes per day for the past year;
  2. indicate that they smoke in the car or home ≥ 3 times per week; and
  3. do not use non-cigarette tobacco (e.g., cigars, chewing tobacco).

For the vaping group caregivers must:

  1. exclusively use EC for the past 3 months (no cigarette or other tobacco use); and
  2. no one living in the home is a current tobacco smoker or has smoked in the home for the past 6 months; and
  3. have a breath carbon monoxide reading of ≤ 6ppm.
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControlToe nail clippingsThis group will provide 2 breath carbon monoxide (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings will be taken from this group.
SmokingToe nail clippingsThis group will provide 1 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
VapingSaliva sampleThis group will provide 2 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
ControlUrine SampleThis group will provide 2 breath carbon monoxide (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings will be taken from this group.
ControlSaliva sampleThis group will provide 2 breath carbon monoxide (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings will be taken from this group.
SmokingBreath carbon monoxide testThis group will provide 1 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
VapingToe nail clippingsThis group will provide 2 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
VapingBreath carbon monoxide testThis group will provide 2 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
ControlBreath carbon monoxide testThis group will provide 2 breath carbon monoxide (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings will be taken from this group.
SmokingSaliva sampleThis group will provide 1 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
SmokingUrine SampleThis group will provide 1 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
VapingUrine SampleThis group will provide 2 breath carbon monoxide test (reading of ≤ 6 parts per million) and a saliva sample, urine sample, and toe nail clippings.
Primary Outcome Measures
NameTimeMethod
Assessment of lung functionDay 1

Child lung function will be measured at the study visit. Forced expiratory volume in the first second will be assessed.

Secondary Outcome Measures
NameTimeMethod
Assessment of cotinine in salivaDay 1

Child saliva samples will be collected at the study visit. Samples will be assessed for cotinine levels.

Assessment of cotinine in urineDay 1

Child urine samples will be collected at the study visit. Samples will be assessed for cotinine levels.

Assessment of nicotine in toenail clippingsDay 1

Child toenail samples will collected at the study visit. Samples will be assessed for nicotine levels.

Assessment of tobacco specific nitrosamine in toenail clippingsDay 1

Child toenail samples will be collected at the study visit. Samples will be assessed for NNAL levels.

Assessment of cotinine in toenail clippingsDay 1

Child toenail samples will be collected at the study visit. Samples will be assessed for cotinine levels.

Assessment of tobacco specific nitrosamine in urineDay 1

Child urine samples will be collected at the study visit. Samples will be assessed for NNAL levels.

Trial Locations

Locations (2)

Uf Ctsi Crc

🇺🇸

Gainesville, Florida, United States

OUHSC

🇺🇸

Oklahoma City, Oklahoma, United States

© Copyright 2025. All Rights Reserved by MedPath